|
View: |
Part 1: Document Description
|
|
Citation |
|
|---|---|
|
Title: |
Dataset for The Cost of COVID-19 Vaccine Delivery at Selected Sites in Bangladesh |
|
Identification Number: |
doi:10.7910/DVN/TBRDQV |
|
Distributor: |
Harvard Dataverse |
|
Date of Distribution: |
2024-04-09 |
|
Version: |
1 |
|
Bibliographic Citation: |
ThinkWell, 2024, "Dataset for The Cost of COVID-19 Vaccine Delivery at Selected Sites in Bangladesh", https://doi.org/10.7910/DVN/TBRDQV, Harvard Dataverse, V1 |
|
Citation |
|
|
Title: |
Dataset for The Cost of COVID-19 Vaccine Delivery at Selected Sites in Bangladesh |
|
Identification Number: |
doi:10.7910/DVN/TBRDQV |
|
Authoring Entity: |
ThinkWell |
|
Distributor: |
Harvard Dataverse |
|
Access Authority: |
Moi, Flavia |
|
Depositor: |
Moi, Flavia |
|
Date of Deposit: |
2024-04-09 |
|
Holdings Information: |
https://doi.org/10.7910/DVN/TBRDQV |
|
Study Scope |
|
|
Keywords: |
Medicine, Health and Life Sciences, Social Sciences, Immunization delivery costs, Vaccine delivery costs, COVID-19, Bangladesh |
|
Abstract: |
This study is part of a multi-country research project that utilizes standardized methods to generate cost evidence on the delivery of COVID-19 (C19) vaccines in Vietnam, Bangladesh, and the Philippines in Asia, and Mozambique, Côte d’Ivoire, the Democratic Republic of Congo, and Uganda in Africa. This was a bottom-up costing study to estimate the cost of delivering C19 vaccines in Bangladesh through fixed and temporary vaccination sites. Fixed sites included ministry of health (MOH) hospital-based sites, non-MOH government hospitals, and outreach EPI centers, and temporary sites included school-based and mass campaign sites. The study included start up and recurrent costs incurred by the government and partners for all relevant activities. Data covered the full financial and economic cost incurred at fixed sites and the Expanded Program on Immunization (EPI) headquarters from April to June 2022, and specific time periods for temporary sites between November 2021 and November 2022, as well as labor data for fixed sites from February 2021 to June 2022. Data was collected from 38 vaccination sites, EPI headquarters, and from World Health Organization (WHO) and UNICEF, through a partnership between ThinkWell and the Institute of Health Economics (IHE). This study also estimated costs incurred by beneficiaries to receive the C19 vaccine at fixed urban sites, and a qualitative assessment on the funding flows and operational and financial challenges of the C19 vaccination program. |
|
Methodology and Processing |
|
|
Sources Statement |
|
|
Data Access |
|
|
Other Study Description Materials |
|
|
Related Publications |
|
|
Citation |
|
|
Title: |
Hossain M.T., Yesmin A., Islam M.M., Moi F., Archer R., Boonstoppel L. 2024. Results tables for Analysis of the Cost of COVID-19 Vaccine Delivery at Selected Sites in Bangladesh. Geneva: ThinkWell |
|
Bibliographic Citation: |
Hossain M.T., Yesmin A., Islam M.M., Moi F., Archer R., Boonstoppel L. 2024. Results tables for Analysis of the Cost of COVID-19 Vaccine Delivery at Selected Sites in Bangladesh. Geneva: ThinkWell |
|
Label: |
Bangladesh C19_raw data.xlsx |
|
Text: |
This file presents the raw cost data used to estimate the cost of delivering and receiving C19 vaccines, as well as to estimate descriptive statistics on staffing and service delivery. Costs are presented as 2022 BDG and 2022 USD. |
|
Notes: |
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
|
Label: |
Bangladesh C19_results.xlsx |
|
Text: |
This file presents the results from the costing analysis, including costs incurred by the health system and by beneficiaries. Results are presented as unit costs (cost per dose delivered) in 2022 USD. |
|
Notes: |
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |